[Immunotherapy of cancer with BCG].
D000276:Adjuvants, Immunologic; D000818:Animals; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use*; D002473:Cell Wall / Q000276:immunology; D006168:Guinea Pigs; D006801:Humans; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D051379:Mice; D009163:Mycobacterium bovis / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D014199:Trehalose
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D014199:Trehalose